ISY1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.413600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.936380E-02
Normal-vs-Stage2
7.078800E-01
Normal-vs-Stage3
3.031000E-01
Normal-vs-Stage4
4.868400E-01
Stage1-vs-Stage2
2.593800E-02
Stage1-vs-Stage3
6.838800E-01
Stage1-vs-Stage4
1.206220E-01
Stage2-vs-Stage3
1.852970E-01
Stage2-vs-Stage4
2.144000E-01
Stage3-vs-Stage4
1.508640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.340400E-01
Normal-vs-AfricanAmerican
7.959200E-01
Normal-vs-Asian
4.687000E-01
Caucasian-vs-AfricanAmerican
7.728400E-01
Caucasian-vs-Asian
9.131800E-01
AfricanAmerican-vs-Asian
7.070600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.439200E-01
Normal-vs-Female
6.379000E-01
Male-vs-Female
8.743400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.011200E-01
Normal-vs-Age(41-60Yrs)
9.921800E-01
Normal-vs-Age(61-80Yrs)
4.408200E-01
Normal-vs-Age(81-100Yrs)
8.781200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.614600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.287200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.754600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.195500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.125400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.483500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.783800E-01
Normal-vs-Daily Drinker
7.173600E-01
Normal-vs-Weekly Drinker
5.348600E-01
Normal-vs-Occasional Drinker
9.517000E-01
Normal-vs-Social Drinker
7.444600E-01
Non Drinker-vs-Daily Drinker
3.114600E-01
Non Drinker-vs-Weekly Drinker
5.631800E-01
Non Drinker-vs-Occasional Drinker
1.377840E-01
Non Drinker-vs-Social Drinker
2.771200E-01
Daily Drinker-vs-Weekly Drinker
7.444800E-01
Daily Drinker-vs-Occasional Drinker
5.993400E-01
Daily Drinker-vs-Social Drinker
8.933200E-01
Weekly Drinker-vs-Occasional Drinker
4.343600E-01
Weekly Drinker-vs-Social Drinker
6.460000E-01
Occasional Drinker-vs-Social Drinker
7.077800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.667000E-01
Normal-vs-Grade 2
7.680400E-01
Normal-vs-Grade 3
7.034000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.737460E-03
Grade 1-vs-Grade 3
1.155170E-04
Grade 1-vs-Grade 4
9.667000E-01
Grade 2-vs-Grade 3
1.079210E-01
Grade 2-vs-Grade 4
7.680400E-01
Grade 3-vs-Grade 4
7.034000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.538200E-01
Normal-vs-NonDiabetic
5.142800E-01
Diabetic-vs-NonDiabetic
4.539200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.331600E-01
Normal-vs-NoPancreatitis
5.654600E-01
Pancreatitis-vs-NoPancreatitis
4.701800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.975000E-01
Normal-vs-N1
7.335000E-01
N0-vs-N1
2.611800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.947200E-01
Normal-vs-TP53-NonMutant
3.829400E-01
TP53-Mutant-vs-TP53-NonMutant
1.633070E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
